Invivoscribe Begins Commercial Shipments of PrepQuant™ Systems, Enabling High-Sensitivity Sample Preparation for MRD Testing Invivoscribe®, a global leader in precision diagnostics and measurable residual disease (MRD) testing, announced that commercial shipments of the PrepQuant™ System have begun in North America. First…
Magnolia Advanced Materials Launches Complete Advanced Materials Product Suite for eVTOL Manufacturers Magnolia Advanced Materials, Inc., a custom formulator of high-performance epoxy systems for aerospace, defense and industrial applications, today announced that its recently formed Research and Development (R&D) team…
Measuring Muscles with Quantitative MRI: New Study Published in Neurology Expands the Evidence for Using MRI Biomarkers in SBMA AMRA Medical is pleased to announce the publication of new research in Neurology demonstrating the potential of quantitative whole-body MRI to measure disease progression…
Revelation Biosciences Selects Avance Clinical as CRO for Phase 2/3 TITAN Study Revelation Biosciences, Inc., a clinical-stage life sciences company focused on developing innovative therapies for acute and chronic diseases, has announced the selection of Avance Clinical as the contract…
TAGRISSO® (osimertinib) plus savolitinib demonstrated statistically significant and clinically meaningful improvements in progression-free and overall survival in MET-driven EGFR-mutated lung cancer after progression on TAGRISSO Positive high-level results from the SAFFRON Phase III trial showed TAGRISSO® (osimertinib) plus savolitinib demonstrated a…
Protolabs Supports MIT Industrial Performance Center Research Fellows to Accelerate U.S. Medical and Aerospace Manufacturing Innovation Protolabs the world’s leading provider of digital manufacturing services, today announced a grant to support research fellows at the MIT Industrial Performance Center as…
Silvec Announces EPA Registration for its Novel Therapy Delivery Technology Silvec Biologics Inc., a Maryland-based agricultural biotechnology company, is pleased to announce that its novel RNA-based therapy delivery product is now registered for unconditional commercial use under the U.S. Environmental…
Eastern Technologies Launches COOLGARD Non-Phosphorus Chemistry Line for Industrial Cooling Water Eastern Technologies, Inc. a Sylmar company and custom formulator of industrial water treatment chemistries, today announced the launch of its COOLGARD Non-Phosphorus product line. The line gives ETI’s partners…
ViiV Healthcare’s 2-drug regimen Dovato is as effective as 3-drug regimen Biktarvy in first-of-its-kind head-to-head study in treatment-naïve adults living with HIV ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, announced data to be presented this…
Verici Dx Receives New York State Approval, Establishing Nationwide Access to Tutivia™ Kidney Transplant Rejection Test Verici Dx plc a developer of advanced clinical diagnostics for organ transplant, announced it has received clinical laboratory accreditation from the New York State…
cTAP Announces Novel Prognostic Score Developed for Duchenne Muscular Dystrophy Patients Offers Improved Prediction of Loss of Ambulation The Collaborative Trajectory Analysis Project (cTAP) announces the publication of a novel, validated prognostic score for predicting the loss of ambulation (LoA)…
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit BeOne Medicines Ltd. a global oncology company, announced the presentation of a large Phase 3 dataset in patients with chronic lymphocytic leukemia or small…